Pulmonx Corp (LUNG)
Healthcare
Medical Devices
—
1.60 $
+1.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Pulmonx Corp (LUNG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.5% of the shares are freely tradable; institutional investors hold 79.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
79.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
4.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
87.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
42Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| PRIMECAP Management Company | 11.19 | 4,724,991 | -0.1 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 9.46 | 3,993,562 | -4.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 6.60 | 2,788,323 | +36.8 | 03/31/2026 |
| BlackRock Inc | 6.30 | 2,661,607 | -1.6 | 03/31/2026 |
| Vanguard Group Inc | 6.01 | 2,540,535 | +13.3 | 12/31/2025 |
| ExodusPoint Capital Management, LP | 4.60 | 1,943,834 | -0.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.87 | 1,634,264 | +0.0 | 03/31/2026 |
| Bank of America Corp | 2.76 | 1,166,826 | +60.3 | 03/31/2026 |
| Deutsche Bank AG | 2.76 | 1,163,678 | +3.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth | 8.53 | 3,602,001 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.